Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-29 2019-09-26 90113
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Avoided shortage 2020-05-06 2020-05-12 114152
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 200MG 300MG TABLET Resolved 2022-01-26 2022-02-04 153490
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201

Showing 21 to 28 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1